An HIV vaccine. (Mujahid Safodien/AFP via Getty Images) Companies have halted an advanced trial of an HIV vaccine because the shot was found to not prevent infection.
Results from the stage 3 trial led to the determination that the vaccine “was not effective in preventing HIV infection compared to placebo among study participants,” Johnson & Johnson and its partners said in a statement.
The vaccine, dubbed Mosiaco, was developed by Janssen, a Johnson & Johnson subsidiary.The study’s Data and Safety Monitoring Board, or a group of independent experts that was monitoring the research, made the determination.The study is being discontinued because […]
Article Source: www.theepochtimes.com
In these tough financial times, you need a company you can trust with stewardship of your life’s savings. We recommend self-directed IRAs backed by physical precious metals provided by Genesis, a faith-driven gold and silver company.